QQ客服 官方微博 反馈留言

	Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma
	Li, Fei; Xu, Yan; Deng, Ping; Yang, Ye; Sui, Weiwei; Jin, Fengyan; Hao, Mu; Li, Zengjun; Zang, Meirong; Zhou, Dehui
	2015
卷号	6期号:11页码:9434-9444
关键词	12p13 deletion CD27 gene prognosis bortezomib multiple myeloma
ISSN号	1949-2553
DOI	10.18632/oncotarget.3319
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6662167
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Li, Fei,Xu, Yan,Deng, Ping,et al. Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma[J],2015,6(11):9434-9444.
APA	Li, Fei.,Xu, Yan.,Deng, Ping.,Yang, Ye.,Sui, Weiwei.,...&Qiu, Lugui.(2015).Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.,6(11),9434-9444.
MLA	Li, Fei,et al."Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma".6.11(2015):9434-9444.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。